Ophthalmology Therapeutics Market | Increasing Prevalence of Eye Diseases to Boost the Market Growth

The global ophthalmology therapeutics market size is poised to grow by USD 10.42 billion during 2020-2024, progressing at a CAGR of almost 6% throughout the forecast period, according to the latest report by Technavio. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. Download a Free Sample of REPORT with COVID-19 Crisis and Recovery Analysis.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201009005248/en/

Technavio has announced its latest market research report titled Global Ophthalmology Therapeutics Market 2020-2024 (Graphic: Business Wire)

The prevalence of eye diseases is one of the critical reasons that will drive ophthalmology therapeutics market growth. Eye diseases such as age-related macular degeneration negatively impact the personal, economic, and social life of an individual. The growing prevalence of eye diseases such as diabetic retinopathy, diabetic macular edema, and RVO result in an increased number of patients that have irreversible blindness and visual impairment. People with Type 1 diabetes are at high risk of developing diabetic retinopathy. These factors will boost the demand for ophthalmology therapeutics, driving the market growth.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Report Highlights:

The major ophthalmology therapeutics market growth came from the retinal disorder therapeutics segment. The retinal disorder therapeutics segment is the major contributor to ophthalmology therapeutics market growth because of the factors such as the growing incidence of retinal disorders, the availability of drugs to treat retinal disorders, and the presence of a strong drug pipeline. Market growth in this segment will be faster than the growth of the market in the glaucoma therapeutics, dry eye disease therapeutics segment.
North America accounted for the largest ophthalmology therapeutics market share in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The prevalence of eye diseases will significantly influence ophthalmology therapeutics market growth in this region.
The global ophthalmology therapeutics market is fragmented. AbbVie Inc., Aerie Pharmaceuticals Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd. are some of the major market participants. To help clients improve their market position, this ophthalmology therapeutics market forecast report provides a detailed analysis of the market leaders.
As the business impact of COVID-19 spreads, the global ophthalmology therapeutics market 2020-2024 is expected to have Neutral and At par growth. As the pandemic spreads in some regions and plateaus in other regions, we revaluate the impact on businesses and update our report forecasts.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Development of Novel Drug Delivery Systems will be a Key Market Trend

The development of novel drug delivery systems will also drive the growth of the ophthalmology therapeutics market. Novel therapeutics and new drug delivery systems are gaining prominence because of their bioavailability to the targeted site, their prolonged action, and the ability to minimize adverse effects. Researchers are coming up with various delivery systems to ensure the sustained delivery of glaucoma and ocular hypertensive medications.

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Ophthalmology Therapeutics Market 2020-2024: Key Highlights

CAGR of the market during the forecast period 2020-2024
Detailed information on factors that will assist ophthalmology therapeutics market growth during the next five years
Estimation of the ophthalmology therapeutics market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the ophthalmology therapeutics market
Analysis of the market’s competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of ophthalmology therapeutics market vendors

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product
Comparison by product
Retinal disorder therapeutics – Market size and forecast 2019-2024
Glaucoma therapeutics – Market size and forecast 2019-2024
Dry eye disease therapeutics – Market size and forecast 2019-2024
Eye infections and inflammation therapeutics –
Market size and forecast 2019-2024
Other therapeutics – Market size and forecast 2019-2024
Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation
Geographic comparison
North America – Market size and forecast 2019-2024
Europe – Market size and forecast 2019-2024
Asia – Market size and forecast 2019-2024
ROW – Market size and forecast 2019-2024
Key leading countries
Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers
Market challenges

PART 11: MARKET TRENDS

Development of novel drug delivery systems
Increase in strategic alliances
Increasing research on gene therapy products

PART 12: VENDOR LANDSCAPE

Overview
Landscape disruption
Competitive scenario

PART 13: VENDOR ANALYSIS

Vendors covered
Vendor classification
Market positioning of vendors
AbbVie Inc.
Aerie Pharmaceuticals Inc.
Bayer AG
F. Hoffmann-La Roche Ltd.
Novartis AG
Otsuka Holdings Co. Ltd.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Santen Pharmaceutical Co. Ltd.
Teva Pharmaceutical Industries Ltd.

PART 14: APPENDIX

PART 15: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201009005248/en/

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

Source Article